Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

Abstract: Systems and methods are disclosed that provide smart alerts to users, e.g., alerts to users about diabetic states that are only provided when it makes sense to do so, e.g., when the system can predict or estimate that the user is not already cognitively aware of their current condition, e.g., particularly where the current condition is a diabetic state warranting attention. In this way, the alert or alarm is personalized and made particularly effective for that user. Such systems and methods still alert the user when action is necessary, e.g., a bolus or temporary basal rate change, or provide a response to a missed bolus or a need for correction, but do not alert when action is unnecessary, e.g., if the user is already estimated or predicted to be cognitively aware of the diabetic state warranting attention, or if corrective action was already taken.

Abstract: Certain aspects of the present disclosure relate generally to configuring applications used in conjunction with medical devices in order to help with monitoring and improving the patient's health. Certain aspects include a method including receiving a request for assets including access information associated with a user of a computing device, the access information including feature customization information for a health intervention application and being issued by an account management service for the health intervention application, and validating that the access information is valid.

Abstract: A high-pressure valve assembly is provided. The high-pressure aerator valve assembly includes an outer housing with front and back ends terminating a central passageway; a movable valve member having a one-piece unitary metal construction slidably engaged within the central passageway in the outer housing, the valve member having an enlarged head termination sealing the front end of the passageway. The assembly also includes a spring-loaded spring guide member also having a one-piece unitary metal construction which is fixed within the central passageway in the outer housing intermediate the front and back end and a wave spring having a predetermined spring constant for supplying spring tension to keep the moveable valve member sealed. Also included are operational sensors which include a linear shaft displacement counter for counting the number of times the valve member opens and closes; a vibration sensor, or accelerometer, for measuring vibration, a temperature sensor and/or an air pressure sensor.

Abstract: A sanitary high pressure valve assembly is provided. The valve assembly includes an inlet adaptor for admitting pressurized gas into a sanitary central passageway for release into a storage vessel containing granular material for the purpose of aiding flow of the granular material from the storage vessel. The valve assembly also includes an isolation chamber for housing serviceable parts that are isolated from the sanitary central passageway.

Abstract: A high-pressure valve assembly is provided. The high-pressure aerator valve assembly includes an outer housing with front and back ends terminating a central passageway; a movable valve member having a one-piece unitary metal construction slidably engaged within the central passageway in the outer housing, the valve member having an enlarged head termination sealing the front end of the passageway. The assembly also includes a spring-loaded spring guide member also having a one-piece unitary metal construction which is fixed within the central passageway in the outer housing intermediate the front and back end and a wave spring having a predetermined spring constant for supplying spring tension to keep the moveable valve member sealed. Also included are operational sensors which include a linear shaft displacement counter for counting the number of times the valve member opens and closes; a vibration sensor, or accelerometer, for measuring vibration, a temperature sensor and/or an air pressure sensor.

Abstract: A sanitary high pressure valve assembly is provided. The valve assembly includes an inlet adaptor for admitting pressurized gas into a sanitary central passageway for release into a storage vessel containing granular material for the purpose of aiding flow of the granular material from the storage vessel. The valve assembly also includes an isolation chamber for housing serviceable parts that are isolated from the sanitary central passageway.

Abstract: A sanitary high pressure valve assembly is provided. The valve assembly includes an inlet adaptor for admitting pressurized gas into a sanitary central passageway for release into a storage vessel containing granular material for the purpose of aiding flow of the granular material from the storage vessel. The valve assembly also includes an isolation chamber for housing serviceable parts that are isolated from the sanitary central passageway.

Abstract: A sanitary high pressure valve assembly is provided. The valve assembly includes an inlet adaptor for admitting pressurized gas into a sanitary central passageway for release into a storage vessel containing granular material for the purpose of aiding flow of the granular material from the storage vessel. The valve assembly also includes an isolation chamber for housing serviceable parts that are isolated from the sanitary central passageway.

Abstract: The present invention relates to multilayered structures. In various embodiments, the present invention provides an at least partially transparent multilayered structure that includes at least one first layer including at least one polyolefin, and at least one second layer including at least one of a cyclic olefin copolymer and a cyclic olefin polymer. In various embodiments, the present invention provides methods of making such multilayered structures, and photobioreactors having compartments including such multilayered structures.

Abstract: The present invention relates to multilayered structures. In various embodiments, the present invention provides an at least partially transparent multilayered structure that includes at least one first layer including at least one polyolefin, and at least one second layer including at least one of a cyclic olefin copolymer and a cyclic olefin polymer. In various embodiments, the present invention provides methods of making such multilayered structures, and photobioreactors having compartments including such multilayered structures.

Abstract: A system for distributing messages to consumers. A consumer may opt-in to receive messages by sending a text message with a keyword to an aggregator. The aggregator is a message distributor and the opt-in message opts in for a particular advertiser and other advertisers. The advertiser may send messages to the consumer and other consumers who specifically opt in for the advertiser. Other advertisers may send messages to the consumer if sufficiently nearby or related to the advertiser, or if sharing a consumer cloud of the advertiser. The advertisers may manage all messages using a mobile or other interface. Messages are sent for a fee. A portion of the fee is remitted to charitable organizations identified for such purpose by recipient consumers receiving the messages. Messages sent by advertisers may include text messages, emails or instant messages.

Abstract: A supported davit arm extension assembly for a descent apparatus comprising an escape shuttle suspended from a cable defining a descent path from an initial point at a receiver of a platform to a terminal point proximate to a ground surface. The extension assembly comprises a davit arm extending above the platform and secured to the receiver, and a fall arrest trolley operatively coupled to the shuttle at a first end and terminating at a second end extending substantially away from the terminal point. The second end of the fall arrest trolley has a securement point for connection to and support of a load, such as a worker, by an overhead fall arrest. While the shuttle is docked with the receiver, the fall arrest trolley extends over the platform, supported by the davit arm, and facilitates substantially unfettered movement of the worker around the platform. As the worker enters the shuttle, it is disengaged from the receiver and follows the descent path of the cable toward the ground surface.

Abstract: Compositions are described herein that are nutritional supplements that contain free amino acids. These supplements contain a homogenous mixture of free amino acids, wherein the free-form amino acids comprise L-Lysine, L-Valine, L-Tryptophan, L-Phenylalanie, L-methionine, L-Leucine, L-Threonine, L-Isoleucine, L-Arginine, L-Histindine, L-Tyrosine, L-Carnitine, L-Serine, L-Glutamine, Aspartic Acid, L-Proline, L-Glycine, Taurine, L-Cysteine, Gamma-aminobutyric acid (GABA), L-Alanine, L-Glutamic acid, and wherein the composition comprises at least one B vitamin. These compositions are of use to treat disorders associated with a deficiency at least one amino acid, such as soft tissue injury, insomnia, panic attacks, anxiety disorders, eating disorders, anorexia, depression, chronic pain, emotional distress, chemical dependence, alcoholism, and hypoglycemia.

Abstract: Compositions are described herein that are nutritional supplements that contain free amino acids. These supplements contain a homogenous mixture of free amino acids, wherein the free-form amino acids comprise L-Lysine, L-Valine, L-Tryptophan, L-Phenylalanine, L-methionine, L-Leucine, L-Threonine, L-Isoleucine, L-Arginine, L-Histidine, L-Tyrosine, L-Carnitine, L-Serine, L-Glutamine, Aspartic Acid, L-Proline, L-Glycine, Taurine, L-Cysteine, Gamma-aminobutyric acid (GABA), L-Alanine, L-Glutamic acid, and wherein the composition comprises at least one B vitamin. These compositions are of use to treat disorders associated with a deficiency at least one amino acid, such as soft tissue injury, insomnia, panic attacks, anxiety disorders, eating disorders, anorexia, depression, chronic pain, emotional distress, chemical dependence, alcoholism, and hypoglycemia.

Abstract: An isolated and purified ?-N-acetyl-D-galactosaminidase from Clostridium perfringens and homologs thereof are disclosed. A method for purifying and isolating the ?-N-acetylgalactosaminidase from Clostridium perfringens by removing neuramidases is disclosed. A process for using the ?-N-acetylgalactosaminidase from Clostridium perfringens in altering type A blood cells to type O blood cells is disclosed. A process for altering cells expressing blood group A epitope by using ?-N-acetylgalactosaminidase isolated from Clostridium perfringens in altering the cells expressing blood group A epitope to cells expressing blood group O epitope is disclosed.

Abstract: Methods, systems and circuits for analyzing the performance of a vehicle having an electrical system are provided which determine a shift point while the vehicle is being driven. The shift point is determined using acceleration data and RPM data generated from the electrical system.

Abstract: Methods, systems and circuits for analyzing the performance of a vehicle having an electrical system are provided which determine a shift point while the vehicle is being driven. The shift point is determined using acceleration data and RPM data generated from the electrical system.